Obstructive Sleep Apnea Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
Condition: OSA Interventions: Drug: Atomoxetine 80 mg plus Oxybutynin 5 mg; Drug: Atomoxetine 80 MG; Drug: Placebo Sponsor: Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2023 Category: Research Source Type: clinical trials
